{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:15:46Z","timestamp":1790673346352,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81272880"],"award-info":[{"award-number":["81272880"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Committee of Science and Technology (China)","award":["124119b1300"],"award-info":[{"award-number":["124119b1300"]}]},{"name":"Shanghai Municipal Health Bureau (China)","award":["20124186"],"award-info":[{"award-number":["20124186"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12967-016-0832-x","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T19:30:52Z","timestamp":1458329452000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Human epithelial-type ovarian tumour marker beta-2-microglobulin is regulated by the TGF-\u03b2 signaling pathway"],"prefix":"10.1186","volume":"14","author":[{"given":"Wenwen","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xulei","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daibing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxiong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,16]]},"reference":[{"issue":"2","key":"832_CR1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/030089168807400202","volume":"74","author":"L Melillo","year":"1988","unstructured":"Melillo L, Musto P, Tomasi P, Cascavilla N, Bodenizza C, Ladogana S, et al. Serum beta 2-microglobulin in malignant lymphoproliferative disorders. Tumori. 1988;74(2):129\u201335.","journal-title":"Tumori"},{"issue":"9","key":"832_CR2","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.4049\/jimmunol.139.9.3132","volume":"139","author":"D Gussow","year":"1987","unstructured":"Gussow D, Rein R, Ginjaar I, Hochstenbach F, Seemann G, Kottman A, et al. The human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit. J Immunol. 1987;139(9):3132\u20138.","journal-title":"J Immunol"},{"issue":"4","key":"832_CR3","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.4049\/jimmunol.127.4.1542","volume":"127","author":"A Liabeuf","year":"1981","unstructured":"Liabeuf A, le de Kaouel Borgne C, Kourilsky FM, Malissen B, Manuel Y, Sanderson AR. An antigenic determinant of human beta 2-microglobulin masked by the association with HLA heavy chains at the cell surface: analysis using monoclonal antibodies. J Immunol. 1981;127(4):1542\u20138.","journal-title":"J Immunol"},{"issue":"2","key":"832_CR4","first-page":"471","volume":"4","author":"B Klein","year":"1994","unstructured":"Klein B, Levin I, Lurie H, Nyska A, Shapira J, Kravits M, et al. Elevated pretreatment levels of soluble CD8 and Beta-2-microglobulin as indicators of relapse in breast-cancer patients. Int J Oncol. 1994;4(2):471\u20134.","journal-title":"Int J Oncol"},{"issue":"12","key":"832_CR5","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/sj.bjc.6604399","volume":"98","author":"J Shrout","year":"2008","unstructured":"Shrout J, Yousefzadeh M, Dodd A, Kirven K, Blum C, Graham A, et al. Beta(2)microglobulin mRNA expression levels are prognostic for lymph node metastasis in colorectal cancer patients. Br J Cancer. 2008;98(12):1999\u20132005. doi: 10.1038\/sj.bjc.6604399 .","journal-title":"Br J Cancer"},{"issue":"7","key":"832_CR6","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1002\/ijc.28484","volume":"134","author":"T Sasaki","year":"2014","unstructured":"Sasaki T, Ravindranath MH, Terasaki PI, Freitas MC, Kawakita S, Jucaud V. Gastric cancer progression may involve a shift in HLA-E profile from an intact heterodimer to beta2-microglobulin-free monomer. Int J Cancer. 2014;134(7):1558\u201370. doi: 10.1002\/ijc.28484 .","journal-title":"Int J Cancer"},{"issue":"1","key":"832_CR7","first-page":"35","volume":"8","author":"K Charalabopoulos","year":"2003","unstructured":"Charalabopoulos K, Papalimneou V, Charalabopoulos A, Zoganas L, Andronadi V, Stefanou D, et al. Serum estimation of carcinoembryonic antigen, beta(2)-microglobulin and calcitonin as tumor markers in primary lung cancer. J BUON. 2003;8(1):35\u20137.","journal-title":"J BUON"},{"issue":"1","key":"832_CR8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1834-7819.1992.tb00832.x","volume":"37","author":"W Manzar","year":"1992","unstructured":"Manzar W, Raghavan MR, Aroor AR, Keshavamurthy KR. Evaluation of serum beta 2-microglobulin in oral cancer. Aust Dent J. 1992;37(1):39\u201342.","journal-title":"Aust Dent J"},{"issue":"5","key":"832_CR9","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/j.1879-3479.1979.tb00471.x","volume":"16","author":"SK Khoo","year":"1979","unstructured":"Khoo SK, Daunter B, Mackay E. Carcinoembryonic antigen and beta 2-microglobulin as serum tumor markers in women with genital cancer. Int J Gynaecol Obstet. 1979;16(5):388\u201393.","journal-title":"Int J Gynaecol Obstet"},{"issue":"7","key":"832_CR10","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1158\/1078-0432.CCR-06-1156","volume":"13","author":"M Gross","year":"2007","unstructured":"Gross M, Top I, Laux I, Katz J, Curran J, Tindell C, et al. Beta-2-microglobulin is an androgen-regulated secreted protein elevated in serum of patients with advanced prostate cancer. Clin Cancer Res. 2007;13(7):1979\u201386. doi: 10.1158\/1078-0432.CCR-06-1156 .","journal-title":"Clin Cancer Res"},{"issue":"5","key":"832_CR11","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/0090-4295(80)90614-7","volume":"16","author":"H Johnson Jr","year":"1980","unstructured":"Johnson H Jr, Flye MW, Javadpour N. Serum beta 2 microglobulin levels in patients with testicular cancer. Urology. 1980;16(5):522\u20134.","journal-title":"Urology"},{"issue":"4","key":"832_CR12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.molimm.2013.05.242","volume":"56","author":"MJ Pokrass","year":"2013","unstructured":"Pokrass MJ, Liu MF, Lindorfer MA, Taylor RP. Activation of complement by monoclonal antibodies that target cell-associated beta(2)-microglobulin: implications for cancer immunotherapy. Mol Immunol. 2013;56(4):549\u201360. doi: 10.1016\/j.molimm.2013.05.242 .","journal-title":"Mol Immunol"},{"issue":"3","key":"832_CR13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/18715206113139990092","volume":"14","author":"T Nomura","year":"2014","unstructured":"Nomura T, Huang WC, Zhau HE, Josson S, Mimata H, Chung LW. Beta2-Microglobulin-mediated signaling as a target for cancer therapy. Anticancer Agents Med Chem. 2014;14(3):343\u201352.","journal-title":"Anticancer Agents Med Chem"},{"issue":"1","key":"832_CR14","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/ijc.28338","volume":"134","author":"AB Campo del","year":"2014","unstructured":"del Campo AB, Kyte JA, Carretero J, Zinchencko S, Mendez R, Gonzalez-Aseguinolaza G, et al. Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma. Int J Cancer. 2014;134(1):102\u201313. doi: 10.1002\/ijc.28338 .","journal-title":"Int J Cancer"},{"issue":"4","key":"832_CR15","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/ijc.26453","volume":"131","author":"C Bossard","year":"2012","unstructured":"Bossard C, Bezieau S, Matysiak-Budnik T, Volteau C, Laboisse CL, Jotereau F, et al. HLA-E\/beta2 microglobulin overexpression in colorectal cancer is associated with recruitment of inhibitory immune cells and tumor progression. Int J Cancer. 2012;131(4):855\u201363. doi: 10.1002\/ijc.26453 .","journal-title":"Int J Cancer"},{"issue":"24","key":"832_CR16","doi-asserted-by":"crossref","first-page":"7294","DOI":"10.1158\/1078-0432.CCR-06-2060","volume":"12","author":"T Nomura","year":"2006","unstructured":"Nomura T, Huang WC, Zhau HE, Wu D, Xie Z, Mimata H, et al. Beta2-microglobulin promotes the growth of human renal cell carcinoma through the activation of the protein kinase A, cyclic AMP-responsive element-binding protein, and vascular endothelial growth factor axis. Clin Cancer Res. 2006;12(24):7294\u2013305. doi: 10.1158\/1078-0432.CCR-06-2060 .","journal-title":"Clin Cancer Res"},{"issue":"4","key":"832_CR17","first-page":"781","volume":"55","author":"DR Rowley","year":"1995","unstructured":"Rowley DR, Dang TD, McBride L, Gerdes MJ, Lu B, Larsen M. Beta-2 microglobulin is mitogenic to PC-3 prostatic carcinoma cells and antagonistic to transforming growth factor beta 1 action. Cancer Res. 1995;55(4):781\u20136.","journal-title":"Cancer Res"},{"issue":"8","key":"832_CR18","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/emboj\/19.8.1745","volume":"19","author":"J Massague","year":"2000","unstructured":"Massague J, Wotton D. Transcriptional control by the TGF-beta\/Smad signaling system. EMBO J. 2000;19(8):1745\u201354. doi: 10.1093\/emboj\/19.8.1745 .","journal-title":"EMBO J"},{"issue":"12","key":"832_CR19","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1046\/j.1365-2443.2002.00599.x","volume":"7","author":"K Miyazawa","year":"2002","unstructured":"Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K. Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells. 2002;7(12):1191\u2013204.","journal-title":"Genes Cells"},{"issue":"18","key":"832_CR20","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200005043421807","volume":"342","author":"GC Blobe","year":"2000","unstructured":"Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med. 2000;342(18):1350\u20138. doi: 10.1056\/NEJM200005043421807 .","journal-title":"N Engl J Med"},{"key":"832_CR21","first-page":"660","volume-title":"World Cancer Report 2014","author":"J Prat","year":"2014","unstructured":"Prat J, Franceschi S. Cancers of the female reproductive organs. In: Stewart BW, Wild CP, editors. World Cancer Report 2014. Lyon: International Agency for Research on Cancer; 2014. p. 660\u201383."},{"issue":"16","key":"832_CR22","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1158\/0008-5472.CAN-13-0023","volume":"73","author":"TL Yeung","year":"2013","unstructured":"Yeung TL, Leung CS, Wong KK, Samimi G, Thompson MS, Liu J, et al. TGF-beta modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment. Cancer Res. 2013;73(16):5016\u201328. doi: 10.1158\/0008-5472.CAN-13-0023 .","journal-title":"Cancer Res"},{"issue":"8","key":"832_CR23","doi-asserted-by":"crossref","first-page":"e42436","DOI":"10.1371\/journal.pone.0042436","volume":"7","author":"JC Cheng","year":"2012","unstructured":"Cheng JC, Auersperg N, Leung PC. TGF-beta induces serous borderline ovarian tumor cell invasion by activating EMT but triggers apoptosis in low-grade serous ovarian carcinoma cells. PLoS One. 2012;7(8):e42436. doi: 10.1371\/journal.pone.0042436 .","journal-title":"PLoS One"},{"issue":"7","key":"832_CR24","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/ijc.25494","volume":"128","author":"MP Ween","year":"2011","unstructured":"Ween MP, Lokman NA, Hoffmann P, Rodgers RJ, Ricciardelli C, Oehler MK. Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells. Int J Cancer. 2011;128(7):1570\u201384. doi: 10.1002\/ijc.25494 .","journal-title":"Int J Cancer"},{"issue":"4","key":"832_CR25","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3892\/ijo.2014.2261","volume":"44","author":"X Wang","year":"2014","unstructured":"Wang X, Gui L, Zhang Y, Zhang J, Shi J, Xu G. Cystatin B is a progression marker of human epithelial ovarian tumors mediated by the TGF-beta signaling pathway. Int J Oncol. 2014;44(4):1099\u2013106. doi: 10.3892\/ijo.2014.2261 .","journal-title":"Int J Oncol"},{"issue":"4","key":"832_CR26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00109-011-0829-0","volume":"90","author":"YH Lee","year":"2012","unstructured":"Lee YH, Kim JH, Zhou H, Kim BW, Wong DT. Salivary transcriptomic biomarkers for detection of ovarian cancer: for serous papillary adenocarcinoma. J Mol Med. 2012;90(4):427\u201334. doi: 10.1007\/s00109-011-0829-0 .","journal-title":"J Mol Med"},{"issue":"4","key":"832_CR27","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1007\/s12032-012-0165-4","volume":"29","author":"U Kucukgoz Gulec","year":"2012","unstructured":"Kucukgoz Gulec U, Paydas S, Guzel AB, Buyukkurt S, Seydaoglu G, Vardar MA, et al. Comparative analysis of CA 125, ferritin, beta-2 microglobulin, lactic dehydrogenase levels in serum and peritoneal fluid in patients with ovarian neoplasia. Med Oncol. 2012;29(4):2937\u201343. doi: 10.1007\/s12032-012-0165-4 .","journal-title":"Med Oncol"},{"key":"832_CR28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1755-8794-2-71","volume":"2","author":"NJ Bowen","year":"2009","unstructured":"Bowen NJ, Walker LD, Matyunina LV, Logani S, Totten KA, Benigno BB, et al. Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells. BMC Med Genomics. 2009;2:71. doi: 10.1186\/1755-8794-2-71 .","journal-title":"BMC Med Genomics"},{"key":"832_CR29","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1186\/1471-2407-14-750","volume":"14","author":"K Li","year":"2014","unstructured":"Li K, Du H, Lian X, Yang S, Chai D, Wang C, et al. Characterization of beta2-microglobulin expression in different types of breast cancer. BMC Cancer. 2014;14:750. doi: 10.1186\/1471-2407-14-750 .","journal-title":"BMC Cancer"},{"issue":"1","key":"832_CR30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10735-014-9597-9","volume":"46","author":"J Sun","year":"2015","unstructured":"Sun J, Yang ZL, Miao X, Zou Q, Li J, Liang L, et al. ATP5b and beta2-microglobulin are predictive markers for the prognosis of patients with gallbladder cancer. J Mol Histol. 2015;46(1):57\u201365. doi: 10.1007\/s10735-014-9597-9 .","journal-title":"J Mol Histol"},{"issue":"24","key":"832_CR31","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.4161\/cbt.8.24.9982","volume":"8","author":"HS Yang","year":"2009","unstructured":"Yang HS, Li Y, Deng HX, Peng F. Identification of beta2-microglobulin as a potential target for ovarian cancer. Cancer Biol Ther. 2009;8(24):2323\u20138.","journal-title":"Cancer Biol Ther"},{"issue":"7","key":"832_CR32","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1158\/0008-5472.CAN-10-3382","volume":"71","author":"S Josson","year":"2011","unstructured":"Josson S, Nomura T, Lin JT, Huang WC, Wu D, Zhau HE, et al. Beta2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells. Cancer Res. 2011;71(7):2600\u201310. doi: 10.1158\/0008-5472.CAN-10-3382 .","journal-title":"Cancer Res"},{"key":"832_CR33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1752-0509-3-73","volume":"3","author":"H Qin","year":"2009","unstructured":"Qin H, Chan MW, Liyanarachchi S, Balch C, Potter D, Souriraj IJ, et al. An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules. BMC Syst Biol. 2009;3:73. doi: 10.1186\/1752-0509-3-73 .","journal-title":"BMC Syst Biol"},{"issue":"2","key":"832_CR34","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/0002-9378(92)91697-9","volume":"166","author":"A Berchuck","year":"1992","unstructured":"Berchuck A, Rodriguez G, Olt G, Whitaker R, Boente MP, Arrick BA, et al. Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-beta. Am J Obstet Gynecol. 1992;166(2):676\u201384.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"832_CR35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1447-0756.2007.00478.x","volume":"33","author":"AS Wong","year":"2007","unstructured":"Wong AS, Leung PC. Role of endocrine and growth factors on the ovarian surface epithelium. J Obstet Gynaecol Res. 2007;33(1):3\u201316.","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"832_CR36","first-page":"49","volume":"16","author":"MR Cardillo","year":"1997","unstructured":"Cardillo MR, Yap E, Castagna G. Molecular genetic analysis of TGF-beta1 in ovarian neoplasia. J Exp Clin Cancer Res. 1997;16(1):49\u201356.","journal-title":"J Exp Clin Cancer Res"},{"issue":"16","key":"832_CR37","first-page":"4507","volume":"60","author":"D Wang","year":"2000","unstructured":"Wang D, Kanuma T, Mizunuma H, Takama F, Ibuki Y, Wake N, et al. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer. Cancer Res. 2000;60(16):4507\u201312.","journal-title":"Cancer Res"},{"issue":"12","key":"832_CR38","first-page":"4679","volume":"61","author":"T Chen","year":"2001","unstructured":"Chen T, Triplett J, Dehner B, Hurst B, Colligan B, Pemberton J, et al. Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas. Cancer Res. 2001;61(12):4679\u201382.","journal-title":"Cancer Res"},{"issue":"19","key":"832_CR39","first-page":"4227","volume":"58","author":"MA Lynch","year":"1998","unstructured":"Lynch MA, Nakashima R, Song H, DeGroff VL, Wang D, Enomoto T, et al. Mutational analysis of the transforming growth factor beta receptor type II gene in human ovarian carcinoma. Cancer Res. 1998;58(19):4227\u201332.","journal-title":"Cancer Res"},{"issue":"4","key":"832_CR40","first-page":"246","volume":"14","author":"O Toutirais","year":"2003","unstructured":"Toutirais O, Chartier P, Dubois D, Bouet F, Leveque J, Catros-Quemener V, et al. Constitutive expression of TGF-beta1, interleukin-6 and interleukin-8 by tumor cells as a major component of immune escape in human ovarian carcinoma. Eur Cytokine Netw. 2003;14(4):246\u201355.","journal-title":"Eur Cytokine Netw"},{"issue":"1","key":"832_CR41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00262-007-0347-7","volume":"57","author":"TM Carr","year":"2008","unstructured":"Carr TM, Adair SJ, Fink MJ, Hogan KT. Immunological profiling of a panel of human ovarian cancer cell lines. Cancer Immunol Immunother. 2008;57(1):31\u201342. doi: 10.1007\/s00262-007-0347-7 .","journal-title":"Cancer Immunol Immunother"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-016-0832-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T08:02:08Z","timestamp":1692259328000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.translational-medicine.com\/content\/14\/1\/75"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,16]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["832"],"URL":"https:\/\/doi.org\/10.1186\/s12967-016-0832-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,16]]},"article-number":"75"}}